Literature DB >> 10655014

Effect of clozapine on polypharmacy.

S A Chong1, G J Remington, K Z Bezchlibnyk-Butler.   

Abstract

Prescribing patterns for a group of outpatients with schizophrenia were surveyed for changes after the initiation of clozapine. Data were drawn from computerized pharmacy records, direct case record reviews, and interviews with the attending psychiatrists. The number of patients with two or more psychotropic drugs decreased by 31 percent after the initiation of clozapine, and a trend toward the use of clozapine without additional neuroleptics was detected. Decreases occurred in the use of anticholinergic agents, carbamazepine, and benzodiazepines, but selective serotonin reuptake inhibitors and sodium valproate were more likely to be prescribed concomitantly with clozapine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10655014     DOI: 10.1176/appi.ps.51.2.250

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  7 in total

Review 1.  Treatment-refractory schizophrenia.

Authors:  P F Buckley; L D Wiggins; S Sebastian; B Singer
Journal:  Curr Psychiatry Rep       Date:  2001-10       Impact factor: 5.285

Review 2.  Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009.

Authors:  Juan A Gallego; John Bonetti; Jianping Zhang; John M Kane; Christoph U Correll
Journal:  Schizophr Res       Date:  2012-04-24       Impact factor: 4.939

Review 3.  A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy.

Authors:  William G Honer; Ric M Procyshyn; Eric Y H Chen; G William MacEwan; Alasdair M Barr
Journal:  J Psychiatry Neurosci       Date:  2009-11       Impact factor: 6.186

4.  Clozapine users in Australia: their characteristics and experiences of care based on data from the 2010 National Survey of High Impact Psychosis.

Authors:  D J Siskind; M Harris; A Phillipou; V A Morgan; A Waterreus; C Galletly; V J Carr; C Harvey; D Castle
Journal:  Epidemiol Psychiatr Sci       Date:  2016-07-18       Impact factor: 6.892

5.  Improving quality and diffusing best practices: the case of schizophrenia.

Authors:  Marcela Horvitz-Lennon; Julie M Donohue; Marisa E Domino; Sharon-Lise T Normand
Journal:  Health Aff (Millwood)       Date:  2009 May-Jun       Impact factor: 6.301

6.  Variability of structurally constrained and unconstrained functional connectivity in schizophrenia.

Authors:  Ye Yao; Lena Palaniyappan; Peter Liddle; Jie Zhang; Susan Francis; Jianfeng Feng
Journal:  Hum Brain Mapp       Date:  2015-08-14       Impact factor: 5.038

7.  Clozapine Use in Patients with Early-Stage Schizophrenia in a Chinese Psychiatric Hospital.

Authors:  Wenying Yi; Shenglin She; Jie Zhang; Haibo Wu; Yingjun Zheng; Yuping Ning
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-24       Impact factor: 2.570

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.